MATE Bioservices, Inc

Cureline is a global contract research organization (CRO) specializing in human biospecimen services, including biobanking and laboratory analysis, to support accelerated drug research and development since its inception in 2003. With a robust global clinical network and regulatory expertise, Cureline offers a diverse array of high-quality biospecimens and custom protocols tailored for various therapeutic areas, including oncology, infectious diseases, and neurological disorders. The company operates an extensive HBS biorepository located in the San Francisco Bay area, providing validated human biospecimens for biomarker development and translational research. Cureline has collaborated with over 150 clinical sites worldwide and has successfully completed projects for approximately 700 clients while actively participating in significant NIH scientific consortiums. Generated from the website

YenZym Antibodies LLC, based in Brisbane, CA, is a leading provider of custom antibody services, offering a wide range of specialized solutions for antibody production and purification. With a team of experienced scientists, they are dedicated to meeting the unique requirements of their clients and providing high-quality custom antibodies tailored to specific research needs. From antigen design and affinity purification to customized antibody regimens, YenZym Antibodies offers a comprehensive suite of services, including regular rabbit antibody service, P-site antibody service, chicken antibody service, and goat antibody service. Their expertise and commitment to customer satisfaction make them a trusted partner for researchers seeking reliable and customized antibody solutions.Generated from the website

Delpor, Inc, situated in Brisbane, CA, focuses on the development of innovative once-yearly therapies utilizing cutting-edge technology. The company's officers and directors oversee the strategic vision, with a clear message from the CEO guiding operations. Known for their proprietary technologies such as Prozor TM and Nanopor TM, Delpor's devices offer distinct advantages compared to traditional depot formulations and subcutaneous implants. They specialize in addressing various disease areas including schizophrenia, bipolar disorder, and opioid use disorder. Offering products like DLP-114, DLP-160, and DLP-208, Delpor, Inc, fosters partnerships with international collaborators, engages in sponsored research, and provides opportunities for out-licensing and career advancement. Their commitment to innovation and collaboration propels them as a leader in the pharmaceutical industry. Generated from the website content